Immunity for tumors and microbes after autotransplantation: if you build it, they will (not) come (Q36331221)

13 August 2017

1 reference

title

Immunity for tumors and microbes after autotransplantation: if you build it, they will (not) come (English)

1 reference

13 August 2017

1 reference

Rapoport AP

1

1 reference

PubMed ID

16327812

13 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

Bone Marrow Transplantation

13 August 2017

1 reference

13 August 2017

37

1 reference

13 August 2017

3

1 reference

13 August 2017

239-247

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705242

13 August 2017

0 references

cites work

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Establishing a platform for immunotherapy: clinical outcome and study of immune reconstitution after high-dose chemotherapy with progenitor cell support in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Immune reconstitution, infectious complications and post transplant supportive care measures after autologous blood and marrow transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Timely reconstitution of immune competence affects clinical outcome following autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Protective antibody responses to pneumococcal conjugate vaccine after autologous hematopoietic stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Diminished neo-antigen response to keyhole limpet hemocyanin (KLH) vaccines in patients after treatment with chemotherapy or hematopoietic cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Vaccination of cancer patients against telomerase induces functional antitumor CD8+ T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Identification of a new HLA-A*0201-restricted cryptic epitope from CYP1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Preparation of autologous leukemia and lymphoma vaccines expressing alpha-gal epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Molecular remission of CML after autotransplantation followed by adoptive transfer of costimulated autologous T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

Restoration of immunity in lymphopenic individuals with cancer by vaccination and adoptive T-cell transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

Polysaccharide conjugate vaccine responses in bone marrow transplant patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

Immune reconstitution after transplantation of autologous peripheral CD34+ cells: analysis of predictive factors and comparison with unselected progenitor transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

Age-dependent incidence, time course, and consequences of thymic renewal in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

Use of the anti-idiotype antibody vaccine TriAb after autologous stem cell transplantation in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

CD3- and CD28-dependent induction of PDE7 required for T cell activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

p27kip1 functions as an anergy factor inhibiting interleukin 2 transcription and clonal expansion of alloreactive human and mouse helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705242

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705242

1 reference

13 August 2017

1 reference

PubMed ID

16327812